Seeing Is Believing
POINT Biopharma Global's activity chart (see below) currently has 2 price targets and 1 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 59.67 days.
Most recent stock forecast was given by from CFRA on 22-Oct-2024.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 22-Oct-2024
$105
$105 (0.00%)
1 years 8 months 19 days ago
(22-Oct-2024)
0/1 (0%)
$105 (0.00%)
Hold Since 21-Dec-2023
$12.5
$27
2 years 6 months 20 days ago
(21-Dec-2023)
1/3 (33.33%)
$0.03 (0.24%)
5
Buy Since 26-Jul-2021
$12.5
$17
2 years 8 months 17 days ago
(24-Oct-2023)
1/3 (33.33%)
$-0.16 (-1.26%)
55
Buy Since 14-Dec-2022
$13
2 years 9 months 5 days ago
(06-Oct-2023)
2/2 (100%)
$3.73 (40.24%)
156
Hold
$22
2 years 9 months 7 days ago
(04-Oct-2023)
0/1 (0%)
$13.49 (158.52%)
What is PNT (POINT Biopharma Global) average time for price targets to be met?
Which analyst has the current highest performing score on PNT (POINT Biopharma Global) with a proven track record?
Which analyst has the most public recommendations on PNT (POINT Biopharma Global)?
Which analyst is the currently most bullish on PNT (POINT Biopharma Global)?
Which analyst is the currently most reserved on PNT (POINT Biopharma Global)?